Could a simple foot massage ease chemo nerve pain?
NCT ID NCT07650864
First seen Jun 27, 2026 · Last updated Sep 02, 2026 · Updated 2 times
Summary
This study investigates whether foot massage using a roller can reduce nerve pain caused by chemotherapy in cancer patients. About 80 adults receiving certain chemotherapy drugs will either receive foot massage twice daily for three weeks or continue with routine care. The goal is to see if this simple, non-drug approach can lower pain scores and improve comfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- foot massage with a massage roller
- What this could lead to
- If effective, foot massage could become a simple, drug-free way to ease chemotherapy-related nerve pain and improve quality of life for cancer patients.
- What could go wrong
- This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The effect may be modest or no better than ice therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Feb 2026
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: (1) age ≥18, (2) receiving neurotoxic chemotherapy regimens including Taxanes (Paclitaxel/Docetaxel), Platinum (Carboplatin/Cisplatin), or a combination of both, (3) Having completed at least three cycles of chemotherapy, (4) scoring ≥ 12 on the S-LANSS scale, and ≥ 4 on the VAS, (5) being conscious, cooperative, and able to communicate in Turkish (6) volunteering to participate and providing written informed consent. Exclusion Criteria: (1) peripheral neuropathy pre-dating the chemotherapy (e.g., diabetic, alcoholic, or nutritional neuropathy) (2) receiving non-taxane/non-platinum regimens or Oxaliplatin-based chemotherapy, (3) active skin infections, open wounds, or severe scar tissue on the feet, (4) history of deep vein thrombosis or active bone/spine metastases in the lower extremities, (5) comorbidities affecting the sensory function of the nervous system.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chemotherapy induced pain neuropathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atatürk Üniversitesi
Erzurum, Erzurum, 25080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists map the daily rhythms of chronic pain
- Can zapping two brain regions at once quiet chronic nerve pain?
- Can a mindfulness app ease the stress of hospitalization?
- Zapping the brain to loosen stiff legs and quiet nerve pain in MS?
- Ancient Mind-Body practice put to the test for spinal cord injury pain
- Can a skin injection of ketamine and lidocaine tame CRPS pain?